Panacea Biotec Ltd operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Panacea Biotec Ltd with three other
pharmaceutical manufacturers in Asia:
sales of 2.67 billion Japanese Yen [US$23.70 million]
Hester Pharmaceuticals Limited
(1.36 billion Indian Rupees [US$18.47 million]
of which 86%
was Poultry Vaccines), and
Pharma Foods International Co.Ltd
based in Japan
(7.94 billion Japanese Yen [US$70.54 million]
Panacea Biotec Ltd reported sales of 5.86 billion Indian Rupees (US$79.61 million)
March of 2018.
increase of 8.8%
versus 2017, when the company's sales were 5.39 billion Indian Rupees.
Despite this increase, sales are still
below the level achieved in 2016, when Panacea Biotec Ltd
reported sales of 6.53 billion Indian Rupees.
The sales level in 2018 was fairly close to the level five years ago: in 2013, Panacea Biotec Ltd had sales
of 5.43 billion Indian Rupees.
Sales of Vaccine saw an increase
14.6% in 2018, from
1.63 billion Indian Rupees to 1.87 billion Indian Rupees.